Clinical intelligence & editorial.

Advertisement

Advertisement

Physicians Office Resource's authored articles and clinical reviews, alongside curated literature and news for practical point-of-care guidance and insight.

Showing 1,249–1,260 of 2,098 articles

PubMed

Guideline-Concordant Sedative and Analgesia Use in Critically Ill Patients Receiving Sustained Neuromuscular Blockade.

OBJECTIVES: Given significant harms of awake paralysis, guidelines recommend combination sedation and analgesia during neuromuscular blockade. In this study, we sought to describe guideline-concordant use of parenteral sedation and analgesia during sustained neuromuscular blockade among adults with critical illness. DESIGN: Multicenter, retrospective cohort study. SETTING: ICUs in 871 hospitals across the United States. PATIENTS: Adult patients admitted to an ICU between 2016 and 2022 who...

Neuromuscular Blockade
Feeney ME, Canova AE, Law AC, Walkey AJ, Bosch NA•
PubMed

Genetic Variants in Potassium Channel Genes and Their Clinical Implications in Kazakhstani Patients with Cardiac Arrhythmias.

Background/Objectives: Cardiac arrhythmias are among the leading causes of sudden cardiac death (SCD). Pathogenic variants in potassium channel genes play a key role in inherited arrhythmia syndromes, yet their contribution in Central Asian populations remains poorly characterized. Methods: We performed targeted next-generation sequencing (NGS) using a 96-gene custom Haloplex panel in 79 Kazakhstani patients with clinically diagnosed arrhythmias, including atrioventricular block, sick sinus synd...

Cardiac Arrhythmias
Chamoieva A, Rakhimova S, Abilova Z, Akhmetova A, Akilzhanova G, Zhalbinova M, Daniyarov A, Akilzhanov K, Molkenov A, Kairov U, Kuanysheva A, Shaimardanov N, Abdrakhmanov A, Bekbossynova M, Akilzhanova A•
PubMed

A Case of Pulmonary Thromboembolism in a Child With Steroid-Resistant Nephrotic Syndrome.

A seven-year-old girl with steroid-resistant nephrotic syndrome (SRNS) presented to the Emergency Department with chest pain, palpitations, dyspnea, and generalized edema. She had been receiving immunosuppressants but remained nephrotic. During evaluation, she was found to have an acute occlusive pulmonary thromboembolism (PTE), confirmed by CT pulmonary angiography. Anticoagulation was initiated promptly with heparin, followed by enoxaparin, a low-molecular-weight, long-acting heparin. This ca...

Nephrotic Syndrome
Reyes CA, Khin E•
PubMed

Efficacy and safety of venanprubart, a BTLA agonist antibody, in patients with active systemic lupus erythematosus.

Objectives This phase 2 study’s objective was to determine whether venanprubart is superior to placebo for inducing remission of rash and/or arthritis in patients with at least moderately active systemic lupus erythematosus (SLE). Methods Patients (N = 85) were randomly assigned in a 1:1 ratio to venanprubart (N = 42) or placebo (N = 43) in a multinational, multicentre, randomised, double-blind, placebo-controlled, parallel-group, 2-arm, phase 2 clinical trial. Treatment (450 mg venanprubart...

Systemic Lupus Erythematosus
Ghosh I, Sweeney SE, Moser B, Ferrante A, Witcher JW, Munoz-Briones J, Chang CY, Linnik MD, Vendel AC•
PubMed

Primary multifocal osseous Hodgkin's lymphoma with spinal involvement.

Abstract A 40-year-old male presented with progressive backache; his workup revealed primary multifocal osseous Hodgkin’s lymphoma (PMOHL), which is a very rare primary presentation of Hodgkin’s lymphoma (HL). The common presenting symptoms include localized bone pain and tenderness with or without fever, weight loss or drenching night sweats. Given the rarity of the spine being affected in PMOHL and its symptoms overlapping with conditions like infectious or malignant causes, this case adds me...

Hodgkin's Lymphoma
Nathani NNA, Kumari L, Ali N•
PubMed

Therapeutic Drug Monitoring of the Subcutaneous Formulations of Infliximab and Vedolizumab-Current Knowledge and Future Directions.

Therapeutic drug monitoring of the intravenous formulations of infliximab in particular, but also vedolizumab, has become an important means of optimising these agents to minimise primary and secondary loss of response. More recently subcutaneous formulations of both infliximab and vedolizumab have become widely available. These new molecules offer patients the convenience of self-administration, and also have pharmacokinetic benefits via maintaining high drug levels, reducing the risk of the de...

Infliximab
Massouridis B, Sparrow MP•
PubMed

The Cross-Knit Between Immune Cells and Thyroid Function in Autoimmune Thyroid Disorders: What We Can Learn from Inborn Errors of Immunity.

Highlights What are the main findings?Autoimmune thyroid diseases (AITDs) share key pathogenetic mechanisms with inborn errors of immunity (IEIs), making IEIs a natural model to study immune tolerance breakdown.Genetic and epigenetic perturbations affecting central and peripheral tolerance mechanisms contribute to the development of thyroid autoimmunity. What is the implication of the main findings?Understanding how specific immune defects lead to AITDs enables the identification of precise mo...

Thyroid Disorders
Grilli L, Cillo F, Romano R, Giardino G, Rotondo FR, Vasaturo S, Salerno M, Capalbo D•
PubMed

Attack rate reductions following berotralstat initiation among US patients with hereditary angioedema in the real-world.

Background Hereditary angioedema (HAE) causes recurring swelling attacks, leading to substantial disease burden. This real-world, retrospective study aimed to evaluate HAE attack rates before and after berotralstat initiation stratified by patients’ baseline attack frequency. Methods Specialty Pharmacy data from Optime Care, Inc. (12/2020–01/2024), the sole berotralstat dispenser in the United States, were analyzed. Eligible patients had ≥ 2 berotralstat dispensings (first = index) and ≥ 1 se...

Hereditary Angioedema
Davis-Lorton M, Tachdjian R, Lopez-Gonzalez L, MacKnight SD, Ramasubramanian R, Laliberté F, Gillard P, LiVecchi M, Nestler-Parr S, Lumry WR•
PubMed

Effectiveness and safety of pegylated filgrastim (Pelgraz®) for the prevention of febrile neutropenia during cancer chemotherapy in all-day practice in Germany.

Purpose Febrile neutropenia (FN) is a common side effect of chemotherapy. It may be prevented by granulocyte colony-stimulating factors (G-CSF), requiring customization based on patients’ risk factors, the type of cancer and chemotherapy, and the formulation used. This observational study investigated all-day use of a pegfilgrastim formulation, also available for self-administration. Methods In outpatient clinics across Germany, doctors recorded data of adult patients suffering from a maligna...

Cancer Chemotherapy
Steinmetz T, Jungberg P, Guth D, Knoblich J, Fietz T, Göhler T, Reiser M, Totzke U, Bernhardt K•
PubMed

A digenic contribution of RPGRIP1 and SLC4A4 to juvenile-onset open-angle glaucoma phenotype with concomitant corneal dystrophy.

Juvenile open-angle glaucoma is an uncommon form of glaucoma, generally associated with high IOP and a significant visual field loss. A 15-year-old boy presented with decreased vision in both eyes (BE). His visual acuity with corrective glasses was 6/9 in the right eye (RE) and 6/6 in the left eye (LE). He had a myopic refractive error of −9 D(s) in the RE and −10.5 D(s) in the LE. His intraocular pressure (IOP) in BE was recorded as 50 mmHg, for which he eventually underwent trabeculectomy in...

Open Angle Glaucoma
Gupta V, Malik MA, Panigrahi A, Gupta S, Vanathi M, Kumar A, Sharma A•
PubMed

Prognostic value of the triglyceride-glucose index combined with atherogenic index of plasma for all-cause mortality in critically ill patients with chronic heart failure: a machine learning-driven retrospective cohort study.

Background The triglyceride-glucose index (TyG) and atherogenic index of plasma (AIP) are emerging metabolic biomarkers associated with cardiovascular diseases. However, their combination prognostic value in patients with critical chronic heart failure (CHF) remains unclear. This study aimed to evaluate the combined predictive effect of these two biomarkers and clarify their interactive patterns in this association. Methods 1,238 patients were recruited via the Medical Information Mart for In...

Chronic Heart Failure
Guo W, Cui Y, Yan S, Che S, Sun N, Mei Y, Guo D, Cui L, Yang J, Wang H•
PubMed

Clinical Trial on the Usefulness of an Intensive Low-Density Lipoprotein Cholesterol Treatment and Familial Hypercholesterolemia Screening Clinical Pathway for Acute Coronary Syndrome: The Hokuriku-plus Acute Coronary Syndrome Registry Study - Rationale and Study Design.

Background Acute coronary syndrome (ACS) is the critical situation caused by decreased blood flow of the coronary arteries. The most recent clinical guideline compiled by the Japanese Circulation Society (JCS) recommends lowering low-density lipoprotein cholesterol (LDL-C) to <70 mg/dL in patients with ACS, because of the lack of clinical evidence. It has been shown that there are substantial numbers of patients with familial hypercholesterolemia (FH) among ACS patients. On this basis, we inten...

Hypercholesterolemia
Tada H, Takeji Y, Goten C, Inoue O, Okada H, Yoshida S, Shimojima M, Nomura A, Mori M, Takashima SI, Kato T, Usui S, Sakata K, Hayashi K, Fujino N, Toyama T, Miyagi S, Nagase K, Mizukoshi E, Miwa K, Yoshida T, Higashikata T, Noji Y, Takata M, Fujioka K, Nakahashi T, Otowa K, Mukai Y, Aburadani I, Takatori O, Ohtani K, Omi W, Takamura M•

Stay current

Healthcare information curated for you.

Register to unlock a wealth of healthcare information and medical resources tailored to your healthcare profession.